How much does Keytruda (pembrolizumab) cost?

Ranking of clinics and doctors, patient reviews, prices ,and information from clinics

The average price of immunotherapy with keytruda (pembolizumab) is $2800, the minimum price is $2000, and the maximum price is $6000.
Turkey Germany Israel
Immunotherapy with Keytruda (Pembolizumab) from $2000 from $2150 from $2000
  • Below average
  • Above average
According to 37 clinics presented in the rating info

Highly rated clinics by real patients info

The hospitals ranking is based on 2665 requests, 527 patient reviews, prices, and information from 37 clinics

I'm looking for treatment of...
Get a free consultation with the coordinator
Melanoma Lung cancer Lymphoma Another one
See all clinics keyboard_arrow_right
Bookimed is a free platform for choosing and scheduling treatment options
  • done Effective prices
  • done Customer care support 24/7
  • done Patient reviews
About Bookimed

immunotherapy with keytruda (pembolizumab) Doctors

Information about doctors who accept foreign patients is provided by clinics

Ilan Gil Ron
Hematologist, Radiation oncologist
Sourasky Medical Center
location_on Israel , Tel Aviv
star star star star star_half
109 reviews

Request for details

Ofer Merimsky
Clinical oncologist
Sourasky Medical Center
location_on Israel , Tel Aviv
star star star star star_half
109 reviews

Request for details

Yesim Yildirim
Clinical oncologist, Surgical oncologist
Anadolu Medical Center
location_on Turkey , Istanbul
star star star star star_half
197 reviews

Request for details

Show all doctors keyboard_arrow_right


Fahad Mawlood

Medical editor info

21.07.2017 · Updated 07.11.2019

What is Keytruda (Pembrolizumab)?

Pembrolizumab belongs to the group of the immunotherapy drugs — type of medicine that can treat certain cancers by influencing on patient's immune system. It blocks a protective mechanism of cancer cells and allows the immune system to destroy them. Monoclonal antibody to programmed cell death-1 protein (PD-1) blocks the interaction between PD-1 and its ligands — PD-L1 and PD-L2.

Keytruda prices are specified in this listing. Submit a request to get a personalized quote.

Is Pembrolizumab FDA approved?

On May 23, 2017, the U.S. Food and Drug Administration granted for Pembrolizumab (Keytruda) an accelerated approval — faster approval of drugs for serious conditions that fill an unmet medical need. FDA allowed prescribing immunotherapy new drug to treat patients whose cancers have a specific genetic feature (biomarker).

What are Keytruda success rates?

During the clinical trials of Keytruda, the following indicators were achieved:


The survival rate of patients with 3-4 stages of cancer

6 month


1 year


1,5 years


2 years


Who produces Keytruda?

The manufacturer is Merck & Co., Inc. — an American pharmaceutical company and one of the largest pharmaceutical companies in the world. Research performed at Merck has led to FDA approval of 63 new drugs. Company has developed more new drugs than any other company in the USA.

Need help?

Medical coordinators consult you and help to make the right choice. Bookimed services are free for you and do not affect the clinic's bill.

Get unlimited access
Enter your email to get access to 622 medical centers, 2559 reviews, special offers, and more!
Нажимая "Получить доступ", вы соглашаетесь с Условиями использования и Политикой конфиденциальности

Please confirm that you have read the terms and agree with them